CFO4Life Group, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
CFO4Life Group, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$728,443
+15.2%
7,151
+14.1%
0.17%
+23.5%
Q2 2023$632,243
+19.7%
6,265
+9.1%
0.14%
+13.3%
Q1 2023$528,284
-9.3%
5,742
-10.6%
0.12%
-3.2%
Q4 2022$582,558
+38.0%
6,421
+15.6%
0.12%
+10.7%
Q3 2022$422,000
-6.8%
5,556
+1.5%
0.11%0.0%
Q2 2022$453,000
-8.3%
5,473
-2.8%
0.11%
+7.7%
Q1 2022$494,000
-3.1%
5,632
-3.4%
0.10%
-1.0%
Q4 2021$510,000
+0.8%
5,828
-5.7%
0.10%
-11.0%
Q3 2021$506,000
-4.9%
6,182
+6.1%
0.12%
-4.1%
Q2 2021$532,000
+6.4%
5,828
-0.4%
0.12%
-0.8%
Q1 2021$500,000
-6.4%
5,852
+3.4%
0.12%
-19.0%
Q4 2020$534,000
+8.5%
5,6600.0%0.15%
-8.4%
Q3 2020$492,000
-4.3%
5,660
-3.8%
0.17%
-15.2%
Q2 2020$514,000
+7.1%
5,884
+1.2%
0.20%
-23.3%
Q1 2020$480,000
-15.5%
5,817
-3.1%
0.26%
+7.1%
Q4 2019$568,000
+7.6%
6,002
-1.3%
0.24%
+1.3%
Q3 2019$528,000
-36.2%
6,080
-32.9%
0.24%
-37.3%
Q2 2019$827,000
-5.8%
9,055
-0.8%
0.38%
-8.0%
Q1 2019$878,000
-15.7%
9,130
-24.8%
0.41%
-10.3%
Q4 2018$1,042,000
-6.9%
12,141
-6.5%
0.46%
-7.7%
Q3 2018$1,119,000
-3.3%
12,989
-15.3%
0.50%
+2.7%
Q2 2018$1,157,00015,3280.48%
Other shareholders
NOVARTIS A G shareholders Q2 2021
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 335,936$29,213,0005.81%
Martin Investment Management, LLC 170,759$14,849,0005.36%
Mawer Investment Management Ltd. 8,515,391$740,498,0004.84%
SCHARF INVESTMENTS, LLC 1,212,354$105,426,0004.54%
Hansberger Growth Investors, LP 45,645$3,969,0004.50%
GARLAND CAPITAL MANAGEMENT INC 50,905$4,427,0003.95%
First Fiduciary Investment Counsel, Inc. 193,021$16,785,0003.49%
PROFESSIONAL ADVISORY SERVICES INC 224,087$19,487,0003.48%
WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC 362,047$31,484,0003.29%
WILKINS INVESTMENT COUNSEL INC 126,470$10,998,0003.28%
View complete list of NOVARTIS A G shareholders